Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01250912 · ClinicalTrials.gov registry record · NA
Imaging With a Radio Tracer to Guide VT Ablations
A NA study of Ventricular Tachycardia and Arrhythmia, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01250912: Completed NA study of Ventricular Tachycardia and Arrhythmia, sponsored by University of Maryland, Baltimore.
NCT01250912 is a NA study of Ventricular Tachycardia and Arrhythmia that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 20 participants, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01250912, a NA study of Ventricular Tachycardia and Arrhythmia, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Some patients are at risk for life-threatening fast heart rates. These can frequently be treated by using a catheter inside the heart to burn away the cells that create the fast heart rates. The purpose of this study is to image the nerves inside the heart of those patients. The investigators want to find out if abnormalities in the nervous system in the heart can help the physician to find the area that needs to be burnt away.
Primary Outcome
Scar Measurement on both MIBG 3D map and electroanatomic scare defined as bipolar voltage \<0.5mV using Standard 17-segment American Heart Association areas.
Conditions Studied
Interventions
- DRUG 123I-metaiodobenzylguanidine
Study Locations (1)
Maryland
- University of Maryland Medical Center, EP Lab, Rm. N3W77 - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-03 |
| Est. Completion | 2019-07-01 |
| Phase | NA |
What the finished NCT01250912 record still lists
NCT01250912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 288-participant average among 28 other Ventricular Tachycardia trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Ventricular Tachycardia appearing as the primary indexed condition, and to 1 intervention - of which 123I-metaiodobenzylguanidine is the first listed.
NCT01250912 reports a single indexed study location in Maryland.
Frequently Asked Questions
What is clinical trial NCT01250912 about?
NCT01250912 is a clinical study titled "Imaging With a Radio Tracer to Guide VT Ablations". Some patients are at risk for life-threatening fast heart rates. These can frequently be treated by using a catheter inside the heart to burn away the cells that create the fast heart rates. The purpose of this study is to image the nerves inside the heart of those patients. The investigators want t...
What is the current status of trial NCT01250912?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2010-03. Estimated completion is 2019-07-01.
What conditions does trial NCT01250912 study?
This clinical trial studies the following conditions: Ventricular Tachycardia, Arrhythmia.
What interventions are being tested in trial NCT01250912?
The interventions under investigation include: 123I-metaiodobenzylguanidine (DRUG).
Who is sponsoring clinical trial NCT01250912?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01250912 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ventricular Tachycardia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01250912's enrollment target sits among peer trials
20 26th of 28 higher than 2 of 28 other Ventricular Tachycardia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Ventricular Tachycardia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ventricular Tachycardia Mechanisms
RECRUITING · NA
-
Randomized Assessment of TcMS for VT Storm
RECRUITING · NA
-
Cardiac Radioablation for VT
RECRUITING · NA
-
Ablation-Index Guided Scar-Mediated Ventricular Tachycardia Ablation in Patients With Ischemic Cardiomyopathy
RECRUITING · NA
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
The Z Stitch Early Bed Rest Assessment Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia